References
- Effective Health Care Program. Registries for Evaluating Patient Outcomes: A User's Guide, 3rd ed. Rockville (MD, USA): Agency for Healthcare Research and Quality. [Accessed January 24 2022]. Available at: https://effectivehealthcare.ahrq.gov/products/registries-guide-3rd-edition/overview
- Kodra Y, Weinbach J, Posada-de-la-Paz M, et al. Recommendations for improving the quality of rare disease registries. IJERPH. 2018;15(8):1644.
- Lacaze P, Millis N, Fookes M, et al. Rare disease registries: a call to action. Intern Med J. 2017;47(9):1075–1079.
- Patient registries [Internet]. Amsterdam: European Medicines Agency, 2018. [Accessed January 24 2022]. Available at: https://www.ema.europa.eu/en/human-regulatory/post-authorisation/patient-registries
- Gosavi S, Bhagavat A. Use of chronic disease registries to optimize cardiovascular health. Curr Vasc Pharmacol. 2016;14(5):426–431.
- National Congenital Anomaly and Rare Disease Registration Service [Internet]. GOV.UK. [Accessed May 28 2022]. Available at: https://www.gov.uk/guidance/the-national-congenital-anomaly-and-rare-disease-registration-service-ncardrs
- Project structure – EJPRD – European Joint Programme on Rare Diseases [Internet]. Ejprarediseases.org. [Accessed March 10 2022]. Available at: https://www.ejprarediseases.org/what-is-ejprd/project-structure/
- Vives Corrons J-L, del Mar Mañú Pereira M. Enerca: the European network for patients with rare anaemias. J Rare Dis Diagn Ther. 2015;1:1.
- European Platform on Rare Disease Registration [Internet]. Providing a central access point for information on rare disease patients' registries to all stakeholders. [cited 2022 Mar 10]. Available from: Eu-rd-platform.jrc.ec.europa.eu
- EURODIS-NORT-CORD Joint Declaration of 10 Key Principles for Rare Disease Patient Registries [Internet]. [Accessed January 24 2022]. Available from: https://download2.eurordis.org/documents/pdf/
- Farmakis D, Angastiniotis M, Eleftheriou A. A short guide to the management of transfusion dependent thalassaemia. Nicosia (Cyprus): Thalassaemia International Federation; 2017.
- Inati-Khoriaty A. Sickle cell disease. Nicosia (Cyprus): Thalassaemia International Federation; 2008.
- Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480–487.
- Farmakis D, Giakoumis A, Angastiniotis M, et al. The changing epidemiology of the ageing thalassaemia populations: a position statement of the Thalassaemia International Federation. Eur J Haematol. 2020;105(1):16–23.
- Old J, Eleftheriou A, Angastiniotis M, editors. et al. Prevention of Thalassaemias and other Haemoglobin Disorders: Vol 1: Principles. 2nd ed. Nicosia (Cyprus): Thalassaemia International Federation; 2013.
- THALassaemia In Action: The THALIA project [Internet]. Nicosia: Thalassaemia International Federation. [Accessed January 24. 2022]. Available from: https://thalassaemia.org.cy/thalassaemia-in-action-the-thalia-project/
- Cappellini MD, Viprakasit V, Taher AT, et al. BELIEVE investigators. a phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia. N Engl J Med. 2020;382(13):1219–1231.
- Casu C, Chessa R, Liu A, et al. Minihepcidins improve ineffective erythropoiesis and splenomegaly in a new mouse model of adult β-thalassemia major. Haematologica. 2020;105(7):1835–1844.
- Thompson AA, Walters MC, Kwiatkowski J, et al. Gene therapy in patients with transfusion-dependent β-thalassemia. N Engl J Med. 2018;378(16):1479–1493.
- Farmakis D, Giakoumis A, Cannon L, et al. COVID-19 and Thalassaemia: a position statement of the Thalassaemia International Federation. Eur J Haematol. 2020;105(4):378–386.
- Parissis J, Farmakis D, Triposkiadis F. Heart failure registries: how far can we go? Eur J Heart Fail. 2016;18(6):626–628.
- Noori T, Ghazisaeedi M, Aliabad GM, et al. International comparison of thalassemia registries: challenges and opportunities. Acta Inform Med. 2019;27(1):58–63.
- Isa H, Adegoke S, Madu A, et al. Sickle cell disease clinical phenotypes in Nigeria: a preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database. Blood Cells Mol Dis. 2020;84:102438.
- Mohd Ibrahim H, Muda Z, Othman IS, et al. Observational study on the current status of thalassaemia in Malaysia: a report from the Malaysian Thalassaemia Registry. BMJ Open. 2020;10(6):e037974.
- Nicholson N, Perego A. Interoperability of population-based patient registries. J Biomed Inform. 2020;112S:100074.
- Schüz J, Fored M. Chronic disease registries – Trends and challenges. Methods Inf Med. 2017;56(4):328–329.
- Gliklich RE, Dreyer NA, Leavy MB, editors. Registries for Evaluating Patient Outcomes: A User's Guide, 3rd ed. [Internet]. Rockville (MD, USA): Agency for Healthcare Research and Quality (US); 2014 April. Report No.: 13(14)-EHC111. Available at: https://www.ncbi.nlm.nih.gov/books/NBK208616/
- Gliklich RE, Dreyer NA, Leavy MB, editors. Registries for Evaluating Patient Outcomes: A User's Guide, 3rd ed. [Internet]. Rockville: Agency for Healthcare Research and Quality (US); 2014 April. Report No.: 13(14)-EHC111. Principles of registry ethics, data ownership, and privacy. Available from: https://www.ncbi.nlm.nih.gov/books/NBK208620/
- Haag NC, Logeman T. Data protection, IT security and IT forensics. Hamburg: Intersoft Consulting Services AG. [cited 2022 May 31]. Available from: https://gdpr-info.eu/art-5-gdpr/
- Antoniou Z, Schiza EC, Neokleous K, et al. eHealth Services for the European Reference Network on Rare Anaemias (eENERCA). Stud Health Technol Inform. 2015;213:153–156.
- TIF's e-registry for patients with thalassaemia is ready for piloting. [Internet]. Thalassaemia International Federation. [cited 2022 Mar 10]. Available from: https://thalassaemia.org.cy/news/tifs-electronic-health-record-for-patients-with-thalassaemia-is-ready-for-piloting/